Physician profile
Thomas James Barrett
NPI 1467742734
$23,907.87
in general payments reported to CMS, 2019-2025
7 companies · $20K in 2025
The $20K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $179 · 2021: $147 · 2022: $647 · 2023: $278 · 2024: $1,691 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $2,240 · Travel and Lodging: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,875.00 |
| Food and Beverage | $2,239.71 |
| Travel and Lodging | $1,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $21,245.54 | 2024-2025 | Actis, Velys, Reclaim |
| Stryker Corporation | $1,017.44 | 2019-2024 | Mako, Triathlon |
| Zimmer Biomet Holdings, INC. | $821.90 | 2022-2024 | Persona |
| Depuy Synthes Sales INC. | $504.93 | 2019-2025 | Velys, Na, Monovisc |
| Smith+Nephew, INC. | $175.60 | 2022-2025 | Redapt |
| Eclipse Technology Solutions INC. | $124.94 | 2023 | |
| Pacira Therapeutics, INC. | $17.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.